Sufentanil (citrate)|cas 60561-17-3|DC Chemicals

Sufentanil (citrate)|cas 60561-17-3|DC Chemicals

Sufentanil citrate(R30730) is a powerful synthetic mu-opioid receptor agonist, approximately 5 to 10 times more potent than its parent drug, fentanyl, and 500 times as potent as morphine.

IC50 value:

Target: mu-opioid receptor

Sufentanil, an opioid analgesic, is an analogue of fentanyl, and has been used for the induction and maintenance of anaesthesia, and for postsurgical analgesia.

Product Name: Sufentanil (citrate)|Cat No: DC9525|Cas: 60561-17-3|Molecule Formular: C28H38N2O9S|Molecule Weight: 578.6743|Other names: Sufentanil (citrate)

Sufentanil citrate(R30730) is a powerful synthetic mu-opioid receptor agonist, approximately 5 to 10 times more potent than its parent drug, fentanyl, and 500 times as potent as morphine.
Sufentanil, an opioid analgesic, is an analogue of fentanyl, and has been used for the induction and maintenance of anaesthesia, and for postsurgical analgesia. It has shorter distribution and elimination half-lives, and is a more potent analgesic than fentanyl. In clinical practice, however, intravenously administered sufentanil produces essentially equivalent anaesthesia to fentanyl and is a better anaesthetic than morphine or pethidine (meperidine) for major surgery. It would appear to maintain haemodynamic stability during surgery better than other opioids or inhalational anaesthetics. Postoperative respiratory depression has been reported in a few patients.
sufentanil has been reported to be 6-10 times more potent than fentanyl, depending on the route of administration; it has been registered for intravenous, epidural and subarachnoid administration. Its reported off-label use has included intra-articular and intranasal administration; moreover, it has been applied as an adjunct in peripheral blocks.

For research only, not for human use!